Literature DB >> 1682290

Zuclopenthixol acetate in viscoleo in acutely disturbed psychotic patients.

A Schlosberg1, F Barr.   

Abstract

This report describes an open pilot study of ten acutely disturbed and agitated psychotic patients who received CPT-A zuclopenthixol injections. The dosage ranged from 50 mg to 100 mg. Sedative effects were noticed already after 2 hours, and the patients were all sleepy and sedated after 8 hours. There was a definite improvement in the CGI within 24 hours. The BPRS improved within 24 hours, having the greatest effect on activation, anxiety, depression, and hostile suspiciousness. These effects were sufficient to control these patients. The findings show a rapid onset of therapeutic effect, with no side effects, a duration of 2-3 days and a good local tolerability.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1682290

Source DB:  PubMed          Journal:  Isr J Psychiatry Relat Sci        ISSN: 0333-7308            Impact factor:   0.481


  2 in total

Review 1.  Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses.

Authors:  Kaushadh Jayakody; Roger Carl Gibson; Ajit Kumar; Shalmini Gunadasa
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

2.  An open trial of zuclopenthixol in management of acute psychoses : a multicentered study.

Authors:  J Fernandes; P V Pradhan; P Choudhury; S Chatterji; J Pereira; H Shah; H A Bhinderwala; D M Bhadlikar; R Radhakrishanan
Journal:  Indian J Psychiatry       Date:  1999-07       Impact factor: 1.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.